ATR inhibition sensitizes liposarcoma to doxorubicin by increasing DNA damage
American journal of cancer research (2022) - Comments
pubmed: 35530299  issn: 2156-6976 

Juncheng Cui, Dylan Dean, Francis J Hornicek, Raphael E Pollock, Robert M Hoffman, Zhenfeng Duan